Tehran University of Medical Sciences

Science Communicator Platform

Share By
Smart Biomaterials to Enhance the Efficiency of Immunotherapy in Glioblastoma: State of the Art and Future Perspectives Publisher Pubmed



Abadi B1, 2, 3 ; Yazdanpanah N4, 5 ; Nokhodchi A6 ; Rezaei N4, 5, 7
Authors

Source: Advanced Drug Delivery Reviews Published:2021


Abstract

Glioblastoma multiform (GBM) is considered as the most lethal tumor among CNS malignancies. Although immunotherapy has achieved remarkable advances in cancer treatment, it has not shown satisfactory results in GBM patients. Biomaterial science, along with nanobiotechnology, is able to optimize the efficiency of immunotherapy in these patients. They can be employed to provide the specific activation of immune cells in tumor tissue and combinational therapy as well as preventing systemic adverse effects resulting from hyperactivation of immune responses and off-targeting effect. Advance biomaterials in this field are classified into targeting nanocarriers and localized delivery systems. This review will offer an overview of immunotherapy strategies for glioblastoma and advance delivery systems for immunotherapeutics that may have a high potential in glioblastoma treatment. © 2021
Related Docs
View other Related Docs
1. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy, Cancers (2022)
2. Targeting the Pd-1/Pd-L1 Pathway in Glioblastoma Multiforme: Preclinical Evidence and Clinical Interventions, International Immunopharmacology (2021)
3. Smart Bio-Encapsulation for Immunotherapy, Smart Nanomaterials for Bioencapsulation (2022)
Experts (# of related papers)
Nima Rezaei (4)
Other Related Docs
4. Nanoparticles in Cancer Immunotherapies: An Innovative Strategy, Biotechnology Progress (2021)
5. Nanocarriers in Glioblastoma Treatment: A Neuroimmunological Perspective, Reviews in the Neurosciences (2024)
6. The Safety and Efficacy of Bispecific T-Cell Engagers (Tces) in Patients With Glioma, Clinical and Experimental Medicine (2026)
7. Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy, International Immunopharmacology (2020)
8. Tumor-Associated Macrophages, Nanomedicine and Imaging: The Axis of Success in the Future of Cancer Immunotherapy, Immunotherapy (2017)
9. Local Immunotherapy of Glioblastoma: A Comprehensive Review of the Concept, Journal of Neuroimmunology (2023)
10. New Approaches in Cancer Immunotherapy: Review Article, Tehran University Medical Journal (2018)
11. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
12. Engineered Exosomes for Targeted Glioma Therapy: Overcoming the Blood-Brain Barrier With Nature-Inspired Nanocarriers, Discover Nano (2026)
13. Oncolytic Virotherapy Improves Immunotherapies Targeting Cancer Stemness in Glioblastoma, Biochimica et Biophysica Acta - General Subjects (2024)
14. Chitosan-Based Materials and Strategies in Immunotherapy and Synergistic Immunochemotherapy: A Focus on Gene-Based Immunoregulation and Car-T and Adoptive Cell Transfer, Carbohydrate Polymer Technologies and Applications (2025)
15. The Therapeutic Potential of Targeting Tumor Microenvironment and Modulation of Immunotherapy in Gastrointestinal Cancer, Current Cancer Drug Targets (2025)
16. Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective, International Journal of Pharmaceutics (2024)
17. Tumor Immunology, Clinical Immunology (2022)
18. Lung Cancer Vaccine Strategies: Exploring the Spectrum From Traditional to Rna-Based Platforms, Frontiers in Bioengineering and Biotechnology (2025)
19. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)
20. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)